Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Chan

Showing results (11-20 of 352) with videos related to

Pageof 36
Sort By:
Expert Opinion on Pharmacotherapy|September 30, 2021
An overview of alogliptin + pioglitazone for the treatment of type 2 diabetesBrian Tomlinson, Paul Chan, Christopher Wai Kei Lam
Journal of Environmental Sciences (China)|September 11, 2017
Challenges to quantitative applications of Landsat observations for the urban thermal environmentFeng Chen, Song Yang, Kai Yin, et al.
Expert Review of Endocrinology & Metabolism|April 16, 2020
Postprandial hyperlipidemia as a risk factor in patients with type 2 diabetesBrian Tomlinson, Paul Chan, Christopher Wai Kei Lam
Pharmacogenomics|August 1, 2015
Pharmacogenetics of cutaneous flushing response to niacin/laropiprant combination in Hong Kong Chinese patients with dyslipidemiaMiao Hu, Ya-Ling Yang, Paul Chan, et al.
Expert Opinion on Investigational Drugs|January 22, 2015
Early investigational drugs targeting PPAR-α for the treatment of metabolic diseaseZhong-Min Liu, Miao Hu, Paul Chan, et al.
Retinal Cases & Brief Reports|November 13, 2014
Spectral-domain optical coherence tomography of endogenous fungal endophthalmitisMinhee Cho, Aziz A Khanifar, R V Paul Chan
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Survival After In-Hospital Cardiac Arrest In Critically Ill Patients: Implications For The Covid-19 Pandemic?Saket Girotra, Yuanyuan Tang, Paul Chan, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 13, 2022
An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular diseaseBrian Tomlinson, Elaine Chow, Paul Chan, et al.
Personalized Medicine|February 10, 2021
Personalized medicine in lipid-modifying therapyBrian Tomlinson, Chen-Hsiu Lin, Paul Chan, et al.
Biomed Research International|January 4, 2014
Merit of anisodamine combined with opioid δ-receptor activation in the protection against myocardial injury during cardiopulmonary bypassXuan Hong, Huimin Fan, Rong Lu, et al.
Pageof 36

Showing results (11-20 of 352) with videos related to

Sort By:
Pageof 36
Expert Opinion on Pharmacotherapy|September 30, 2021
An overview of alogliptin + pioglitazone for the treatment of type 2 diabetesBrian Tomlinson, Paul Chan, Christopher Wai Kei Lam
Journal of Environmental Sciences (China)|September 11, 2017
Challenges to quantitative applications of Landsat observations for the urban thermal environmentFeng Chen, Song Yang, Kai Yin, et al.
Expert Review of Endocrinology & Metabolism|April 16, 2020
Postprandial hyperlipidemia as a risk factor in patients with type 2 diabetesBrian Tomlinson, Paul Chan, Christopher Wai Kei Lam
Pharmacogenomics|August 1, 2015
Pharmacogenetics of cutaneous flushing response to niacin/laropiprant combination in Hong Kong Chinese patients with dyslipidemiaMiao Hu, Ya-Ling Yang, Paul Chan, et al.
Expert Opinion on Investigational Drugs|January 22, 2015
Early investigational drugs targeting PPAR-α for the treatment of metabolic diseaseZhong-Min Liu, Miao Hu, Paul Chan, et al.
Retinal Cases & Brief Reports|November 13, 2014
Spectral-domain optical coherence tomography of endogenous fungal endophthalmitisMinhee Cho, Aziz A Khanifar, R V Paul Chan
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Survival After In-Hospital Cardiac Arrest In Critically Ill Patients: Implications For The Covid-19 Pandemic?Saket Girotra, Yuanyuan Tang, Paul Chan, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 13, 2022
An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular diseaseBrian Tomlinson, Elaine Chow, Paul Chan, et al.
Personalized Medicine|February 10, 2021
Personalized medicine in lipid-modifying therapyBrian Tomlinson, Chen-Hsiu Lin, Paul Chan, et al.
Biomed Research International|January 4, 2014
Merit of anisodamine combined with opioid δ-receptor activation in the protection against myocardial injury during cardiopulmonary bypassXuan Hong, Huimin Fan, Rong Lu, et al.
Pageof 36